We are beginning to see the impact of COVID-19 on the research community. Research studies are being delayed or are needing to adjust protocols etc. Many funders and sponsors are sympathetic to the situation and guidance has been issued from major research governance/funding bodies on this.
Please find below links to key information and guidance regarding conducting research in these unprecedented times. The information in this area is rapidly changing so we will continue to update and add guidance as it is issued:
HRA guidance for sponsors, sites and researchers,
MHRA advice for management of clinical trials in relation to coronavirus
NHS Research Scotland guidance for sponsors, sites and researchers.
NIHR guidance on the impact of COVID-19 on research funded or supported by the NIHR
Health and Care Research Wales: COVID-19 Statement
HSC R&D Division, Northern Ireland: COVID-19 Impact on Funded Research
Research Excellence Framework (REF) 2021 contingency planning
Clinical Academics and COVID-19.
Advice from the Royal College of Physicians on behalf of major research funders on returning to clinical practice. This advice also applies to NMAHPs.
British Geriatric Society: recommendations for COVID-19 research with older people.
Organisation | Guidance | Summary of information |
---|---|---|
Wellcome Trust |
Coronavirus (COVID-19): information for grant applicants and grant holders |
|
Cancer Research UK |
Coronavirus (COVID-19): information for grant applicants and grant holders |
|
The Stroke Association |
Research Awards and COVID-19 Arrangements |
|
British Heart Foundation |
Statement on Coronavirus and grants |
|